Overview
- 19 FDA inspections are on record.
- 11 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-11-07.
At a glance
Inspections
19
Form 483s
11
EIRs
3
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 27 Oct 2025 – 7 Nov 2025 | Human Drugs | 483 | View 483 → |
| 1 May 2023 – 5 May 2023 | Human Drugs | Clean | |
| 10 May 2021 – 21 May 2021 | Human Drugs | 483 | View 483 → |
| 4 Feb 2019 – 14 Feb 2019 | Human Drugs | 483 | On file |
| 24 Apr 2017 – 26 May 2017 | Human Drugs | 483 | View 483 → |
| 17 Aug 2015 – 21 Aug 2015 | Human Drugs | 483 | View 483 → |
| 14 Jul 2014 – 25 Jul 2014 | Human Drugs | Clean | |
| 10 Jul 2013 – 16 Aug 2013 | Medical Devices & Rad Health | 483 | View 483 → |
| 16 Apr 2012 | Not recorded | 483 | View 483 → |
| 23 Mar 2011 | Not recorded | 483 | View 483 → |
| 3 Feb 2011 | Not recorded | Clean | |
| 3 Sep 2010 | Not recorded | 483 | View 483 → |
Observations on record
Form 483 observations cited at this site, most recent first.
7 Nov 2025
21 CFR 211.113(b)
Validation lacking for sterile drug products
Cited by Christopher R Czajka, Anney Lin
7 Nov 2025
21 CFR 211.160(b)
Scientifically sound laboratory controls
Cited by Christopher R Czajka, Anney Lin
7 Nov 2025
21 CFR 211.192
Extent of discrepancy, failure investigations
Cited by Christopher R Czajka, Anney Lin
21 May 2021
21 CFR 211.192
Investigations of discrepancies, failures
Cited by Bryan A Galvez, Joel D Hustedt
Investigators
FDA investigators tied to this site in the record.
Caryn M Mcnab3 insp.
Virgilio F Pacio2 insp.
Marcus F Yambot2 insp.
Christopher R Czajka1 insp.
Anney Lin1 insp.
Darren S Brown1 insp.
Michael T Cyrus1 insp.
Dogbeda F Mackenzie1 insp.
Bryan A Galvez1 insp.
Joel D Hustedt1 insp.
Eileen A Liu1 insp.
Jolanna A Norton1 insp.
Andrew K Haack1 insp.
Miguel A Martinez1 insp.
Yasamin Ameri1 insp.
Amanda L Fyles1 insp.
Linda Thai1 insp.
Evelyn Wong1 insp.
Linda L Ng1 insp.
Carla J Lundi1 insp.
Kim L Thomas Cruse1 insp.
Teresa T Cain1 insp.
Vashti E Bocker1 insp.
Jennifer M Gogley1 insp.
Keith P Iams1 insp.
Yvette M Lacour-Davis1 insp.
Vickie L Anderson1 insp.
Binh T Nguyen1 insp.
Deborah A Greco1 insp.
Terrance L Thomas1 insp.
Joey V Quitania1 insp.
Bichsa T Tran1 insp.
Cntrctmntr Anderson1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 8x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 8x |
| 21 CFR 211.113(b) | Cited across public-safe Form 483 observations | 7x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 6x |
| 21 CFR 211.68(a) | Cited across public-safe Form 483 observations | 6x |
| 21 CFR 211.160(a) | Cited across public-safe Form 483 observations | 5x |
| 21 CFR 211.110(a) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.165(e) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.165(f) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.68(b) | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.25(a) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.42(c)(10)(iii) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.42(c)(10)(iv) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.42(c)(3) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.63 | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.100(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.100(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.180(e)(2) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.22(c) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.42(c)(10)(v) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.67(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.84(d)(2) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.160(b)(3) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.166(a)(3) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.167(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.167(c) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.180(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.182 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.186(b)(9) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188(b)(10) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188(b)(7) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(a)(4) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c)(5) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Alliance Medical Products, Inc.'s 11 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat